HOLX
Hologic Inc
NASDAQ · Health Care
$74.81
+0.11 (+0.15%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 4.02B | 4.26B | 7.67B | 7.67B | 6.30B |
| Net Income | 554.94M | 528.68M | 874.62M | 949.43M | 701.56M |
| EPS | — | — | — | — | — |
| Profit Margin | 13.8% | 13.1% | 11.4% | 12.4% | 11.1% |
| Rev Growth | -5.5% | -5.5% | +3.3% | +12.8% | +4.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 2.78B | 2.78B | 2.82B | 3.22B | 3.48B |
| Total Equity | 5.57B | 5.57B | 8.53B | 8.23B | 7.50B |
| D/E Ratio | 0.50 | 0.50 | 0.33 | 0.39 | 0.46 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 721.71M | 725.76M | 1.82B | 1.84B | 1.35B |
| Free Cash Flow | — | — | 922.35M | 975.66M | 594.87M |